1 ） Kimura K‚ Kimura T‚ Ishihara M‚ et al: JCS 2018 Guideline on Diagnosis and Treatment of Acute Coronary Syndrome. Circ J‚ 83: 1085-1196‚ 2019.
2 ） The DECODE study group: Glucose tolerance and mortality: comparison of WHO and American Diabetic Association diagnostic criteria. Lancet‚ 354: 617-21‚ 1999.
3 ） Chiasson JL‚ Josse RG‚ Gomis R‚ et al: Acarbose treatment and the risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance: the STOPNIDDM trial. JAMA‚ 290: 486-94‚ 2003.
4 ） Kosiborod M‚ Rathore SS‚ Inzucchi SE‚ et al: Admission glucose and mortality in elderly patients hospitalized with acute myocardial infarction: implications for patients with and without recognized diabetes. Circulation‚ 111: 3078- 3086‚ 2005.
5 ） Yang SW‚ Zhou YJ‚ Hu DY‚ et al: Association between admission hypoglycaemia and in-hospital and 3-year mortality in older patients with acute myocardial infarction. Heart‚ 96: 1444-1450‚ 2010.
6 ） Takai T‚ Yasuda S‚ Takahashi J‚ et al: Trends in acute myocardial infarction incidence and mortality over 30 years in Japan: report from the MIYAGI-AMI Registry Study. Circ J‚ 74: 93-100‚ 2010.
7 ） Monnier L‚ Mas E‚ Ginet C‚ et al: Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes. JAMA‚ 295: 1681-1687‚ 2006.
8 ） Siegelaar SE‚ Holleman F‚ Hoekstra JBL‚ et al: Glucose variability; does it matter? Endocr Rev‚ 31: 171-82‚ 2010.
9 ） Service FJ‚ Molnar GD‚ Rosevear JW‚ et al: Mean amplitude of glycemic excursions‚ a measure of diabetic instability. Diabetes‚ 19: 644-55‚ 1970.
10） Hori M‚ Nishida K: Oxidative stress and left ventricular remodelling after myocardial infarction. Cardiovasc Res‚ 81: 457-64‚ 2009.
11） Gohbara M‚ Iwahashi N‚ Kataoka S‚ et al: Glycemic Variability Determined by Continuous Glucose Monitoring System Predicts Left Ventricular Remodeling in Patients With a First ST-Segment Elevation Myocardial Infarction. Circ J‚ 79: 1092-1099‚ 2015.
12） Kusama I‚ Hibi K‚ Kosuge M‚ et al: Impact of plaque rupture on infarct size in ST-segment elevation anterior acute myocardial infarction. J Am Coll Cardiol‚ 50: 1230 -7‚ 2007.
13） Okada K‚ Hibi K‚ Gohbara M‚ et al: Association between blood glucose variability and coronary plaque instability in patients with acute coronary syndromes. Cardiovasc Diabetol‚ 14: 111. doi: 10.1186/s12933-015-0275-3‚ 2015.
14） Gohbara M‚ Hibi K‚ Mitsuhashi T‚ et al: Glycemic Variability on Continuous Glucose Monitoring System Correlates With Non-Culprit Vessel Coronary Plaque Vulnerability in Patients With First-Episode Acute Coronary Syndrome – Optical Coherence Tomography Study –. Circ J‚ 80: 202-210‚ 2016.
15） Kataoka S‚ Gohbara M‚ Iwahashi N‚ et al: Glycemic Variability on Continuous Glucose Monitoring System Predicts Rapid Progression of Non-Culprit Lesions in Patients With Acute Coronary Syndrome. Circ J‚ 79: 2246 -54‚ 2015.
16） Nakachi T‚ Kosuge M‚ Hibi K‚ et al: C-reactive protein elevation and rapid angiographic progression of nonculprit lesion in patients with non-ST-segment elevation acute coronary syndrome. Circ J‚ 72: 1953-9‚ 2008.
17） Takahashi H‚ Iwahashi N‚ Kirigaya J‚ et al: Glycemic variability determined with a continuous glucose monitoring system can predict prognosis after acute coronary syndrome. Cardiovasc Diabetol‚ 17: 116. doi: 10.1186/s12933-018-0761-5.
論文の公開元へ
